RenaissanceRe Holdings Ltd. logo

RenaissanceRe Holdings Ltd. (RNR)

Common Stock · Currency in USD · XNYS

RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.

Company Info

SIC6331
Composite FIGI
CIK0000913144
IPOJul 27, 1995
Sectorfire, marine & casualty insurance

Highlights

Market Cap$12.96B
EPS$77.88
P/E Ratio2.43
Revenue$12.81B
Gross Profit$12.79B
Net Income$5.33B
Employees1,040
WSO43,153,808
Phone(441) 295-4513

Related Tickers

Analysis

Share Price Chart

Performance Chart

The chart shows the growth of an initial investment of $10,000 in RenaissanceRe Holdings Ltd., comparing it to the performance of the S&P 500 index.
All prices have been adjusted for splits and dividends.

Returns By Period

RenaissanceRe Holdings Ltd. (RNR) has returned 7.26% so far this year and 32.63% over the past 12 months. Looking at the last ten years, RNR has achieved an annualized return of 9.52%, underperforming the Benchmark (SPY), which averaged 12.23% per year.

RNR

1M0.63%
6M14.59%
YTD7.26%
1Y32.63%
5Y12.26%
10Y9.52%

Benchmark (SPY)

1M-3.85%
6M-2.35%
YTD-4.36%
1Y34.06%
5Y9.80%
10Y12.23%

Monthly Returns

The table below presents the monthly returns of RenaissanceRe Holdings Ltd. (RNR) with color gradation from worst to best to easily spot seasonal factors.

JanFebMarAprMayJunJulAugSepOctNovDec
20260.59%6.50%-2.16%1.38%
2025-6.80%3.51%0.60%0.35%4.44%-2.10%0.20%-0.58%4.45%-0.49%3.09%7.15%
202416.19%-1.50%4.24%-6.70%-2.69%-1.86%2.78%8.92%7.01%-3.66%8.45%-13.27%
20236.21%7.46%-6.78%7.52%-12.51%-0.70%0.23%0.74%4.37%11.03%-3.05%-7.86%
2022-7.49%-4.53%6.57%-9.78%6.97%2.01%-17.20%4.65%4.20%9.73%21.52%-2.27%
2021-9.63%10.66%-4.21%5.50%-9.26%-3.64%2.54%2.65%-11.02%1.25%4.25%8.13%
2020-3.82%-10.23%-12.60%1.34%17.75%0.95%5.15%1.18%-6.87%-4.83%0.83%-0.67%
20194.43%6.16%-2.94%7.64%12.20%2.03%1.11%-0.37%5.61%-3.46%0.01%3.88%
20180.41%-1.95%7.68%-2.07%-9.63%-2.87%9.36%1.11%0.46%-8.63%8.81%-0.54%
20170.27%5.46%-2.89%-1.80%0.13%-3.01%5.03%-5.72%-2.94%2.65%-1.91%-5.63%
2016-6.80%4.05%1.94%0.65%2.13%0.58%3.58%5.38%4.34%

Performance Indicators

The charts below present risk-adjusted performance metrics for RenaissanceRe Holdings Ltd. (RNR) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.

Sharpe ratio

-2.00-1.000.001.002.003.00SPY: 0.92RNR: 0.92

Sortino ratio

-6.00-4.00-2.000.002.004.00RNR: 1.36SPY: 1.40

Omega ratio

0.501.001.502.00RNR: 1.17SPY: 1.22

Calmar ratio

0.002.004.006.00SPY: 1.20RNR: 1.56

Martin ratio

0.001.003.00RNR: 0.35SPY: 0.42

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.

The chart below shows the rolling Sharpe ratio of RNR compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Volatility Chart

The current RenaissanceRe Holdings Ltd. volatility is 0.90%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses.
Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.

Income Statement

The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.

20252023202220212020201920182017201620152014201320122011
Liabilities And Equity (USD)53.80B49.01B36.55B33.96B30.82B26.33B18.68B15.23B12.35B11.56B8.20B8.18B7.93B7.74B
Temporary Equity (USD)7.60B6.10B4.54B3.55B3.39B3.07B2.05B1.30B1.18B1.05B1.13B1.10B968.26M657.73M
Equity Attributable To Parent (USD)11.61B9.45B5.33B6.62B7.56B5.97B5.05B4.39B4.87B4.73B3.87B3.90B3.50B3.61B
Equity Attributable To Noncontrolling Interest (USD)------------3.99M3.34M
Equity (USD)11.61B9.45B5.33B6.62B7.56B5.97B5.05B4.39B4.87B4.73B3.87B3.90B3.51B3.61B
Redeemable Noncontrolling Interest (USD)7.60B6.10B4.54B3.55B3.39B3.07B2.05B1.30B1.18B1.05B1.13B1.10B968.26M657.73M
Long-term Debt (USD)2.33B1.96B1.17B1.17B1.14B1.38B991.13M989.62M948.66M966.08M----
Noncurrent Liabilities (USD)--------------
Current Liabilities (USD)34.59B33.45B26.69B23.78B19.87B17.29B11.58B9.54B6.31B5.78B3.21B3.17B3.45B3.48B
Liabilities (USD)34.59B33.45B26.69B23.78B19.87B17.29B11.58B9.54B6.31B5.78B3.21B3.17B3.45B3.48B
Intangible Assets (USD)332.74M482.07M34.80M41.29M51.00M65.87M56.97M54.47M65.46M82.90M14.98M18.92M22.18M27.54M
Noncurrent Assets (USD)--------------
Current Assets (USD)53.80B49.01B36.55B33.96B30.82B26.33B18.68B15.23B12.35B11.56B8.20B8.18B7.93B7.74B
Assets (USD)53.80B49.01B36.55B33.96B30.82B26.33B18.68B15.23B12.35B11.56B8.20B8.18B7.93B7.74B

News and Insights

VedTechBio® Launches RxAgentAI™ – an Artificial Intelligence and Machine Learning Platform, catering to the decision making and strategic needs of stakeholders in the life sciences industry AND VedTechBio® Announces a Drug Discovery Collaboration with RenaissThera®

VedTechBio, a biopharma-tech company, has launched RxAgentAI, an AI and ML platform for the life sciences industry. It has also announced a drug discovery collaboration with RenaissThera, a biotech company working on metabolic diseases.

GlobeNewswire Inc. faviconGlobeNewswire Inc.
W.R. Berkley (WRB) Boosts Shareholders' Value Via Several Moves

Improved pricing, expansion of international business, reserving discipline, a solid balance sheet and a prudent capital management policy should help W.R. Berkley (WRB) maintain its streak of dividend hikes and special dividends.

Zacks Investment Research faviconZacks Investment ResearchZacks Equity Research
3 Insurance Stocks to Watch on Share Buyback Spree

We focus on AXS, RDN and RNR whose board of directors recently approved new share buyback programs, banking on the confidence that the companies' operational expertise will boost liquidity.

Zacks Investment Research faviconZacks Investment ResearchTanuka De